One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Impact of oral soluble guanylate cyclase stimulators in heart failure: A systematic review and Meta-analysis of randomized controlled trials
NimaMoghaddamMD1NavrajMalhiMD1MustafaTomaMD MSc12
doi : 10.1016/j.ahj.2021.07.003
Volume 241, November 2021, Pages 74-82
Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trial
LuisaFreyerabLukasvon StülpnagelabPeterSpielbichlerabNikolaySapplercFelixWennerabMichaelSchreinlechnercAresaKrasniqiabAmiraBehrozabElodieEiffenerabMartinZensdTheresaDolejsicSteffenMassbergabKonstantinos DRizasab1AxelBauerabc1
doi : 10.1016/j.ahj.2021.06.008
Volume 241, November 2021, Pages 26-34
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations
Thomas J.PovsicMDPhDFACCaTimothy D.HenryMDFACCbE. MagnusOhmanMDFACCaCarl J.PepineMDMACCcRonald G.CrystalMDdTodd K.RosengartMDFACSeRickey R.ReinhardtMDPhDfHoward C.DittrichMDfJay H.TraverseMDgGeoffrey A.AnswiniMDFACShNahush A.MokadamMDi
doi : 10.1016/j.ahj.2021.06.013
Volume 241, November 2021, Pages 38-49
Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis?,?
Robert W.YehMD, MScaWilliamBachinskyMDbRobertStolerMDcCinthiaBatemanMDdJennifer A.TremmelMD, MSeJ. DawnAbbottMDfSuhailDohadMDgWayneBatchelorMDhPaulUnderwoodMDiDominic J.AlloccoMDiAjay J.KirtaneMD, SMj
doi : 10.1016/j.ahj.2021.07.008
Volume 241, November 2021, Pages 101-107
Drug-coated balloon (DCB) technology was developed as an alternative treatment for obstructive coronary artery disease (CAD) and in-stent restenosis (ISR). Management of coronary ISR is clinically challenging and frequently encountered in practice. The Agent DCB uses an inactive excipient to effectively deliver a targeted, therapeutic dose of paclitaxel to the vessel wall.
Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices
KarolinaSzummerMD PhDabcKrishnaPundiMDbcAlexander C.PerinoMDbcJunFanMSccMitraKothariMBBS MPHcMintu P.TurakhiaMD MASbc
doi : 10.1016/j.ahj.2021.06.002
Volume 241, November 2021, Pages 6-13
Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: A multi-center study
Celina M.YongMD,MBA,MScabKateri J.SpinelliPhDcShih TingChiuPhDcBrandonJonesMDcBrianPennyBSdSantoshGummidipundiMSaShireBeachMDeAlexPerinoMDbMintuTurakhiaMD,MASabfPaulHeidenreichMD,MSabTy J.GluckmanMDc
doi : 10.1016/j.ahj.2021.06.011
Volume 241, November 2021, Pages 14-25
Coarctation of aorta is associated with left ventricular stiffness, left atrial dysfunction and pulmonary hypertension
Alexander C.EgbeMBBSMPHWilliam R.MirandaMDHeidi M.ConnollyMDBarry A.BorlaugMD
doi : 10.1016/j.ahj.2021.07.005
Volume 241, November 2021, Pages 50-58
Development and outcomes of hyperkalemia in hospitalized patients: potential implications for care
James B.WetmoreMD, MSabHengYanMSaYiPengMSaDavid T.GilbertsonPhDaCharles A.HerzogMDac
doi : 10.1016/j.ahj.2021.07.006
Volume 241, November 2021, Pages 59-67
Move more – be happier? physical activity and health-related quality of life in children with congenital heart disease
LeonBrudyMScabMichaelMeyerMScabRenateOberhofferMDabPeterEwertMDacJanMüllerPhDab
doi : 10.1016/j.ahj.2021.07.004
Volume 241, November 2021, Pages 68-73
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial
FelixBöhmMD, PhDaBrynjölfurMogensenMDaOllieÖstlundPhDbThomasEngstrømMD, PhDcEigilFossumMD, PhDdGoranStankovicMD, PhDeOskarAngeråsMD, PhDfAndrejs?rglisMD, PhDgMadhavMenonMDhCarlSchultzMDijColinBerryMD, PhDklChristophLiebetrauMD, PhDmnMikaLaineMD, PhDoClaesHeldMD, PhDbpAndreasRückMD, PhDaStefan K.JamesMD, PhDbp
doi : 10.1016/j.ahj.2021.07.007
Volume 241, November 2021, Pages 92-100
Complete revascularization in ST elevation myocardial infarction (STEMI) patients with multivessel disease has resulted in reduction in composite clinical endpoints in medium sized trials. Only one trial showed an effect on hard clinical endpoints, but the revascularization procedure was guided by angiographic evaluation of stenosis severity. Consequently, it is not clear how Fractional Flow Reserve (FFR)-guided percutaneous coronary intervention (PCI) affects hard clinical endpoints in STEMI.
Association between symptoms, affect and heart rhythm in patients with persistent or paroxysmal atrial fibrillation: an ambulatory pilot study
Kevin MWheelockMDaAnnaKratzPhDcSangeetaLathkar-PradhanMBBScKayvanNajarianPhDdJonathanGryakPhDdZhiLiPhDdHakanOralMDbDaniel J.ClauwMDeBrahmajee K.NallamothuMD, MPcHamidGhanbariMD, MPHc
doi : 10.1016/j.ahj.2021.06.003
Volume 241, November 2021, Pages 1-5
Symptoms in atrial fibrillation are generally assumed to correspond to heart rhythm; however, patient affect – the experience of feelings, emotion or mood – is known to frequently modulate how patients report symptoms but this has not been studied in atrial fibrillation. In this study, we investigated the relationship between affect, symptoms and heart rhythm in patients with paroxysmal or persistent atrial fibrillation. We found that presence of negative affect portended reporting of more severe symptoms to the same or greater extent than heart rhythm.
Nationwide cardiovascular disease admission rates during a second COVID-19 lockdown
Daniel MølagerChristensenMDaJawad HaiderButtMDbEmilFosbølMD, PhDbLarsKøberMD, DMScbfChristianTorp-PedersenMD, DMSccdGunnarGislasonMD, PhDaefMatthewPhelpsMPH, PhDa
doi : 10.1016/j.ahj.2021.07.001
Volume 241, November 2021, Pages 35-37
Implementation of a practice plan for the outpatient cardiac evaluation of children after acute SARS-CoV-2 infection and a report of outcomes
Andrew L.Dailey-SchwartzMDab1Jameson A.DyalMDab1William T.MahleMDabMatthew E.OsterMD, MPHab
doi : 10.1016/j.ahj.2021.06.014
Volume 241, November 2021, Pages 83-86
Sex differences in emergency medical services management of patients with myocardial infarction: analysis of routinely collected data for over 110,000 patients
BenjuminHsuPhDabCherylCarcelPhDcXiaWangPhDcSanne A.E.PetersPhDcdeDeborah A.RandallPhDfAlysHavardPhDaMatthewMillerMBBSagJulieRedfernPhDchMarkWoodwardPhDcdiLouisa R.JormPhDa
doi : 10.1016/j.ahj.2021.07.009
Volume 241, November 2021, Pages 87-91
Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials
YimingChenMSabJohnLawrencePhDcNormanStockbridgeMD, PhDd
doi : 10.1016/j.ahj.2021.03.016
Volume 241, November 2021, Pages 108-119
Natriuretic peptides and incident atrial fibrillation
MariaTomasdottirMDaClaesHeldMD, PhDabLarsWallentinMD, PhDabZiadHijaziMD, PhDab
doi : 10.1016/j.ahj.2021.04.015
Volume 241, November 2021, Page 120
The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation
Gurbet ÖzgeMertMDaErdiBabayigitMDbBülentGörenekMDa
doi : 10.1016/j.ahj.2021.04.014
Volume 241, November 2021, Page 121
